Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • travelk
    Member
    • Jul 2013
    • 20

    #1

    Spearman correlation test: FPKM or counts?

    I'm not sure if this is very obvious but I'm not a statistician so I thought I would confirm with the more knowledgeable people on this site.


    I would like to do a Spearman correlation between genes on my RNA-Seq data (which I've seen done in various papers). However, they only say "Spearman correlation on gene expression data" and I don't know if that means on counts or FPKM. I've looked around and some papers do FPKM/RPKM (but not necessarily between genes but rather between conditions/treatments) but in message boards, they normally recommend counts but without explaining why. Can anyone enlighten me? Is there any difference between the two?

    I've normalized the counts using DESeq size factors.

    Thanks for your insight!
  • swbarnes2
    Senior Member
    • May 2008
    • 910

    #2
    RPKM is counts, but corrected for differences in gene length between genes, and differences in overall read numbers between samples. You certainly do need to correct for the fact that not all samples get the same # of reads; you don't want one sample ranking as #1 for every gene because it got twice as many reads as everything else. Correcting for gene length is likely not going to matter since you are ranking.

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
      by SEQadmin2



      Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

      Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
      ...
      10-14-2026, 09:55 AM
    • SEQadmin2
      New Genomics Technologies Take Aim at Long-Standing Limits
      by SEQadmin2


      Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

      We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
      ...
      09-28-2026, 10:25 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 10-22-2026, 11:13 AM
    0 responses
    30 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-22-2026, 10:48 AM
    0 responses
    22 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-15-2026, 10:52 AM
    0 responses
    39 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-14-2026, 05:39 AM
    0 responses
    45 views
    0 reactions
    Last Post SEQadmin2  
    Working...